Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma-Reply

被引：0
|
作者：
Mastrolonardo, Eric V. [1 ]
Llerena, Pablo [1 ]
Curry, Joseph M. [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Dept Otolaryngol Head & Neck Surg, 925 Chestnut St,6th Floor, Philadelphia, PA 1107 USA
来源：
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY | 2025年 / 151卷 / 02期
关键词：
D O I：
10.1001/jamaoto.2024.3965
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cerebral Infarction as a Rare Adverse Event of Immune Checkpoint Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma: A Case Series
    Inoue, Takahiro
    Kumai, Takumi
    Ohara, Kenzo
    Takahara, Miki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [42] PDE5 inhibitors for the immune therapy of head and neck squamous cell carcinoma
    Serafini, P.
    Weed, D.
    Vella, J.
    Delafuente, A.
    Gomez, C. R.
    Rodriguez, Z.
    Walker, G.
    IMMUNOLOGY, 2012, 137 : 719 - 719
  • [43] Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma
    Goldfarb, Jeremy Allan
    Ferrarotto, Renata
    Gross, Neil
    Goepfert, Ryan
    Debnam, James Matthew
    Gunn, Brandon
    Nagarajan, Priyadharsini
    Esmaeli, Bita
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (03) : 320 - 323
  • [44] Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma Reply
    Zhao, Joseph J.
    Pietrantonio, Filippo
    Sundar, Raghav
    JAMA ONCOLOGY, 2023, 9 (07) : 1005 - 1006
  • [45] CCND1 amplification contributes to immunosuppression in head and neck squamous cell carcinoma and the association with a poor response to immune checkpoint inhibitors
    Huang, C.
    Chen, Y.
    Gao, X.
    Li, Y.
    Lin, J.
    Chen, L. Z.
    Chang, L. P.
    Chen, G.
    Guan, Y. F.
    Pan, L. K.
    Xia, X. F.
    Guo, Z. Q.
    Pan, J. J.
    Yi, X.
    Chen, C. B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
    Arribas, Lorena
    Plana, Maria
    Taberna, Miren
    Sospedra, Maria
    Vilarino, Noelia
    Oliva, Marc
    Pallares, Natalia
    Gonzalez Tampan, Ana Regina
    Miguel Del Rio, Luis
    Mesia, Ricard
    Baracos, Vickie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort
    Issa, Majd
    Klamer, Brett G.
    Mladkova, Nikol
    Laliotis, Georgios I.
    Karivedu, Vidhya
    Bhateja, Priyanka
    Byington, Chase
    Dibs, Khaled
    Pan, Xueliang
    Chakravarti, Arnab
    Grecula, John
    Jhawar, Sachin R.
    Mitchell, Darrion
    Baliga, Sujith
    Old, Matthew
    Carrau, Ricardo L.
    Rocco, James W.
    Blakaj, Dukagjin M.
    Bonomi, Marcelo
    BMC CANCER, 2022, 22 (01)
  • [48] Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort
    Majd Issa
    Brett G. Klamer
    Nikol Mladkova
    Georgios I. Laliotis
    Vidhya Karivedu
    Priyanka Bhateja
    Chase Byington
    Khaled Dibs
    Xueliang Pan
    Arnab Chakravarti
    John Grecula
    Sachin R. Jhawar
    Darrion Mitchell
    Sujith Baliga
    Matthew Old
    Ricardo L. Carrau
    James W. Rocco
    Dukagjin M. Blakaj
    Marcelo Bonomi
    BMC Cancer, 22
  • [49] Letter to the Editor: "Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma"
    Haridevamuthu, B.
    ORAL ONCOLOGY, 2024, 156
  • [50] Safety and Efficacy of Intra-Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma
    Yang, Chao
    Zhang, Jin-long
    Li, Zheng
    Liang, Xi-hong
    Zhao, Hong-wei
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,
12345